Evidence map›Paper›PMID 35935106›Full record

ArticleNature synthesis2022

Single-atom logic for heterocycle editing.

Justin Jurczyk, Jisoo Woo, Sojung F Kim, Balu D Dherange, Richmond Sarpong, Mark D Levin

Abstract read
In one paragraph

Article in Nature synthesis, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 183 papers.

0numbers the graph read from it
0cells of the map it votes in
183citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

183 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

123 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Justin JurczykDepartment of Chemistry, University of California, Berkeley, CA, USA.
Jisoo WooDepartment of Chemistry, University of Chicago, Chicago, IL, USA.
Sojung F KimDepartment of Chemistry, University of California, Berkeley, CA, USA.ORCID 0000-0001-5089-8259
Balu D DherangeDepartment of Chemistry, University of Chicago, Chicago, IL, USA.ORCID 0000-0002-4123-5012
Richmond SarpongDepartment of Chemistry, University of California, Berkeley, CA, USA.ORCID 0000-0002-0028-6323
Mark D LevinDepartment of Chemistry, University of Chicago, Chicago, IL, USA.ORCID 0000-0002-4461-363X

Funding

Strategies and Methods for Complex Molecule Synthesis: Acquisition of a 400 MHz Nuclear Magnetic Resonance Spectrometer ConsoleR35GM130345 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI Richmond Sarpong · 2019 to 2026
$5.4M
Construction of Heteroarenes Through Single Atom I-RenewalR35GM142768 · NIGMS · UNIVERSITY OF CHICAGO · PI Mark Daniel Levin · 2021 to 2026
$2.6M
NIGMS NIH HHS R35 GM130345NIGMS NIH HHS R35 GM142768
6 · The paper itself

Abstract

Medicinal chemistry continues to be impacted by new synthetic methods. Particularly sought after, especially at the drug discovery stage, is the ability to enact the desired chemical transformations in a concise and chemospecific fashion. To this end, the field of organic synthesis has become captivated by the idea of 'molecular editing'-to rapidly build onto, change or prune molecules one atom at a time using transformations that are mild and selective enough to be employed at the late stages of a synthetic sequence. In this Review, the definition and categorization of a particularly promising subclass of molecular editing reactions, termed 'single-atom skeletal editing', are proposed. Although skeletal editing applies to both cyclic and acyclic compounds, this Review focuses on heterocycles, both for their centrality in medicinal chemistry and for the definitional clarity afforded by a focus on ring systems. A classification system is presented by highlighting methods (both historically important examples and recent advances) that achieve such transformations, with the goal to spark interest and inspire further development in this growing field.

Identifiers

PMID35935106
PMCPMC9355079

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.